- Home
- ACRV vs TSBK Comparison
ACRV vs TSBK Comparison
Compare ACRV & TSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- TSBK
- Stock Information
- Founded
- ACRV 2018
- TSBK 1915
- Country
- ACRV United States
- TSBK United States
- Employees
- ACRV N/A
- TSBK N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- TSBK Banks
- Sector
- ACRV Health Care
- TSBK Finance
- Exchange
- ACRV Nasdaq
- TSBK Nasdaq
- Market Cap
- ACRV 247.8M
- TSBK 256.3M
- IPO Year
- ACRV 2022
- TSBK 1998
- Fundamental
- Price
- ACRV $8.04
- TSBK $32.96
- Analyst Decision
- ACRV Strong Buy
- TSBK
- Analyst Count
- ACRV 5
- TSBK 0
- Target Price
- ACRV $22.40
- TSBK N/A
- AVG Volume (30 Days)
- ACRV 44.7K
- TSBK 11.0K
- Earning Date
- ACRV 11-13-2024
- TSBK 10-31-2024
- Dividend Yield
- ACRV N/A
- TSBK 3.08%
- EPS Growth
- ACRV N/A
- TSBK N/A
- EPS
- ACRV N/A
- TSBK 3.01
- Revenue
- ACRV N/A
- TSBK $74,154,000.00
- Revenue This Year
- ACRV N/A
- TSBK N/A
- Revenue Next Year
- ACRV N/A
- TSBK N/A
- P/E Ratio
- ACRV N/A
- TSBK $10.97
- Revenue Growth
- ACRV N/A
- TSBK N/A
- 52 Week Low
- ACRV $3.19
- TSBK $23.93
- 52 Week High
- ACRV $11.90
- TSBK $33.98
- Technical
- Relative Strength Index (RSI)
- ACRV 48.60
- TSBK 59.35
- Support Level
- ACRV $7.69
- TSBK $32.50
- Resistance Level
- ACRV $8.54
- TSBK $33.70
- Average True Range (ATR)
- ACRV 0.34
- TSBK 1.00
- MACD
- ACRV -0.03
- TSBK 0.27
- Stochastic Oscillator
- ACRV 23.59
- TSBK 80.00
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. Company also offers loans to real estate, including residential and commercial / multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans and land loans. The company mainly operates in the United States.